Identification of differential biological activity and synergy between the PARP inhibitor rucaparib and its major metabolite.
暂无分享,去创建一个
M. Pujana | A. Antolin | I. Fernandez-Carasa | C. Serra | Huabin Hu | Wenjie Zhang | Aurora Scrivo | Antonella Consiglio | Alvaro Aytes | Amadeu Llebaria